1.
Kayıkçıoğlu E, Onder AH. The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors: Pan-Immune-Inflammation-Value in Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors. Chron Precis Med Res [Internet]. 2022 Oct. 15 [cited 2023 Feb. 3];3(3). Available from: https://chronpmr.com/index.php/cpmr/article/view/145-149